DANIEL ERNESTO
CASTELLANO GAUNA

Profesor asociado

Foto de DANIEL ERNESTO

Foto de Hospital Universitario Virgen Macarena

Hospital Universitario Virgen Macarena

Sevilla, España

Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (5)

2022

Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group
Clinical Genitourinary Cancer, Vol. 20, Núm. 4, pp. 388.e1-388.e10

2016

Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02
Annals of Oncology, Vol. 27, pp. vi277

2015

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis
BMC Cancer, Vol. 15, Núm. 1

2013

Erratum: The role of pharmacogenomics in metastatic renal cell carcinoma (Cancer and Metastasis Reviews (2012) 31:SUPPL. 1 (S29-S32) DOI: 10.1007/s10555-012-9356-x)
Cancer and Metastasis Reviews

2012

The role of pharmacogenomics in metastatic renal cell carcinoma
Cancer and Metastasis Reviews, Vol. 31, pp. S29-S32